Skip to main content
. Author manuscript; available in PMC: 2024 Mar 27.
Published in final edited form as: Am J Obstet Gynecol. 2023 Jun 17;229(4):428.e1–428.e12. doi: 10.1016/j.ajog.2023.06.030

TABLE 1.

Distribution of demographical and clinical variables according to type of RH

Characteristic Total (N=1257) Nerve sparing
RH (n=883)
Non-nerve sparing
RH (n=374)
P value
Age (y) .090
 ≤45 616 (49.0) 419 (47.5) 197 (52.7)
 >45 641 (51.0) 464 (52.5) 177 (47.3)
Pathologic stage <.0001
 IB1 1186 (94.4) 846 (95.8) 340 (90.9)
 IIA1 71 (5.6) 37 (4.2) 34 (9.1)
Grade .259
 1 120 (9.5) 92 (10.4) 28 (7.5)
 2 877 (69.8) 612 (69.3) 265 (70.9)
 3 260 (20.7) 179 (20.3) 81 (21.7)
LVSI <.0001
 No 600 (47.7) 403 (45.6) 197 (52.7)
 Yes 432 (34.4) 291 (33.0) 141 (37.7)
 Unknown 225 (17.9) 189 (21.4) 36 (9.6)
Histology .291a
 Squamous 823 (65.5) 566 (64.1) 257 (68.7)
 Adenocarcinoma 348 (27.7) 253 (28.7) 95 (25.4)
 Adenosquamous 67 (5.3) 50 (5.7) 17 (4.5)
 Others 19 (1.5) 14 (1.5) 5 (1.4)
Diameter <.0001
 ≤20 mm 712 (56.6) 535 (60.6) 177 (47.3)
 21–40 mm 545 (43.4) 348 (39.4) 197 (52.7)
Adjuvant therapy .633
 No 909 (72.3) 642 (72.7) 267 (71.4)
 Yes 348 (27.7) 241 (27.3) 107 (28.6)

LVSI, lymphovascular space invasion; RH, radical hysterectomy.

a

The test was performed on squamous vs adenocarcinoma vs adenosquamous.